KPC Pharmaceuticals Inc  

(Public, SHA:600422)   Watch this stock  
Find more results for 600422
-0.03 (-0.23%)
Feb 22 - Close
SHA data delayed by 1 mins - Disclaimer
Currency in CNY
Range 12.97 - 13.11
52 week 12.33 - 15.85
Open 13.10
Vol. 7.37M
Mkt cap 10.29B
P/E 23.36
EPS 0.56
Shares 788.69M
Dec 13, 2016
KPC Pharmaceuticals Inc Extraordinary Shareholders Meeting

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 7.73% 8.77%
Operating margin 8.58% 9.47%
EBITD margin - 11.36%
Return on average assets 6.57% 10.19%
Return on average equity 9.59% 15.45%
Employees 4,228 -
CDP Score - -


No. 166 Keyi Road, High-tech Development Zone
+86-871-68324311 (Phone)
+86-871-68324267 (Fax)

Website links


KPC Pharmaceuticals, Inc., formerly Kunming Pharmaceutical Corp., is a China-based company principally engaged in manufacture, wholesaling and retailing of pharmaceuticals. The Company provides natural herbal medicines and chemical compound drugs, including drugs for central nervous systems, drugs for cardio and cerebral vascular diseases, anti-parasite drugs, antimicrobial drugs, anti-gout drugs, hormones and endocrine regulation drugs, drugs for hemorrhoids and anti-inflammatory drugs, among others. The Company also involves in pharmaceutical purchasing and distribution, as well as health supplements manufacturing. It distributes its products in domestic and overseas markets.

Officers and directors

Xiaochang Dai President
Age: 52
C.H. Lin Vice Chairman of the Board
Age: 46
Shaoquan Wang Chief Financial Officer
Age: 45
Chaoneng Xu Vice President, Secretary of the Board
Age: 49
Shaoyu Dong Vice President
Age: 56
Zhongzhan Lin Vice President
Age: 44
Peng Liu Vice President
Age: 49
Rong Pei Director
Age: 42
Siyang Wang Director
Age: 26
Wanshou Li Independent Director
Age: 50